AKT inhibitors in combination with first-line chemotherapy [56] and vinorelbine-based combinatorial therapy [57, 58] both showed therapeutic effects in breast cancer cases, and we demonstrated that high CuRG_score was significantly associated with higher IC50 of these drugs. The gene discussed is AKT1; the disease is breast cancer.